| Gary Stremcha, OD | |
|
416 3rd Ave, Havre, MT 59501-3914 | |
| (406) 265-1231 | |
| (406) 265-1603 |
| Full Name | Gary Stremcha |
|---|---|
| Gender | Male |
| Speciality | Optometry |
| Experience | 39 Years |
| Location | 416 3rd Ave, Havre, Montana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194747055 | NPI | - | NPPES |
| 48-3613 | Medicaid | MT | |
| 27360 | Other | MT | BC/BS OF MT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 510 (Montana) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Havre Optometric Clinic Pllp | 1557402542 | 3 |
News Archive
Boston Medical Center (BMC) has been chosen to lead an investigation aimed at developing novel approaches to prevent tuberculosis (TB). Jerrold J. Ellner, MD, chief of the section of infectious diseases at BMC and professor of medicine at the Boston University School of Medicine (BUSM), a renowned expert in the field, will serve as principal investigator (PI) on the five-year, $3 million grant funded by the National Institutes of Health (NIH).
We've all heard about the damage that reactive oxygen species (ROS) - aka free radicals - can do to our bodies and the sales pitches for antioxidant vitamins, skin creams or "superfoods" that can stop them. In fact, there is considerable scientific evidence that chronic ROS production within cells can contribute to human diseases, including insulin resistance and type 2 diabetes.
Influenza outbreaks were shorter and resulted in fewer cases and fewer deaths at long-term care facilities that started residents on preventive antiviral medications within five days of the first case, compared to those that started later, according to a new study in the July 1 issue of Clinical Infectious Diseases, currently available online.
The researchers from the University of Cambridge, Cambridge United Kingdom have published their findings in a study titled, "Rapid implementation of SARS-CoV-2 sequencing to investigate cases of healthcare-associated COVID-19: a prospective genomic surveillance study," in the latest issue of The Lancet Infectious Diseases.
"The Kenyan government's recent failure to adequately treat a patient with extensively drug-resistant tuberculosis (XDR-TB) has some civil society organizations questioning whether the country's TB program is equipped to diagnose and treat such patients," PlusNews reports.
› Verified 3 days ago
| Provider Name | Havre Optometric Clinic Pllp |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1982749362 PECOS PAC ID: 1557402542 Enrollment ID: O20100113000469 |
News Archive
Boston Medical Center (BMC) has been chosen to lead an investigation aimed at developing novel approaches to prevent tuberculosis (TB). Jerrold J. Ellner, MD, chief of the section of infectious diseases at BMC and professor of medicine at the Boston University School of Medicine (BUSM), a renowned expert in the field, will serve as principal investigator (PI) on the five-year, $3 million grant funded by the National Institutes of Health (NIH).
We've all heard about the damage that reactive oxygen species (ROS) - aka free radicals - can do to our bodies and the sales pitches for antioxidant vitamins, skin creams or "superfoods" that can stop them. In fact, there is considerable scientific evidence that chronic ROS production within cells can contribute to human diseases, including insulin resistance and type 2 diabetes.
Influenza outbreaks were shorter and resulted in fewer cases and fewer deaths at long-term care facilities that started residents on preventive antiviral medications within five days of the first case, compared to those that started later, according to a new study in the July 1 issue of Clinical Infectious Diseases, currently available online.
The researchers from the University of Cambridge, Cambridge United Kingdom have published their findings in a study titled, "Rapid implementation of SARS-CoV-2 sequencing to investigate cases of healthcare-associated COVID-19: a prospective genomic surveillance study," in the latest issue of The Lancet Infectious Diseases.
"The Kenyan government's recent failure to adequately treat a patient with extensively drug-resistant tuberculosis (XDR-TB) has some civil society organizations questioning whether the country's TB program is equipped to diagnose and treat such patients," PlusNews reports.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Gary Stremcha, OD Po Box 551, Havre, MT 59501-0551 Ph: (406) 265-1231 | Gary Stremcha, OD 416 3rd Ave, Havre, MT 59501-3914 Ph: (406) 265-1231 |
News Archive
Boston Medical Center (BMC) has been chosen to lead an investigation aimed at developing novel approaches to prevent tuberculosis (TB). Jerrold J. Ellner, MD, chief of the section of infectious diseases at BMC and professor of medicine at the Boston University School of Medicine (BUSM), a renowned expert in the field, will serve as principal investigator (PI) on the five-year, $3 million grant funded by the National Institutes of Health (NIH).
We've all heard about the damage that reactive oxygen species (ROS) - aka free radicals - can do to our bodies and the sales pitches for antioxidant vitamins, skin creams or "superfoods" that can stop them. In fact, there is considerable scientific evidence that chronic ROS production within cells can contribute to human diseases, including insulin resistance and type 2 diabetes.
Influenza outbreaks were shorter and resulted in fewer cases and fewer deaths at long-term care facilities that started residents on preventive antiviral medications within five days of the first case, compared to those that started later, according to a new study in the July 1 issue of Clinical Infectious Diseases, currently available online.
The researchers from the University of Cambridge, Cambridge United Kingdom have published their findings in a study titled, "Rapid implementation of SARS-CoV-2 sequencing to investigate cases of healthcare-associated COVID-19: a prospective genomic surveillance study," in the latest issue of The Lancet Infectious Diseases.
"The Kenyan government's recent failure to adequately treat a patient with extensively drug-resistant tuberculosis (XDR-TB) has some civil society organizations questioning whether the country's TB program is equipped to diagnose and treat such patients," PlusNews reports.
› Verified 3 days ago
Lindsey Wilson, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 416 3rd Ave, Havre, MT 59501 Phone: 406-265-1231 | |
Douglas Arthur Safley, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 416 3rd Ave, Havre, MT 59501 Phone: 406-265-1231 Fax: 406-265-1603 | |
Dr. Erica J Farmer, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 20 13th St W, Box 1231, Havre, MT 59501 Phone: 406-262-2020 Fax: 406-262-1655 | |
Northern Montana Vision Center Optometrist Medicare: Not Enrolled in Medicare Practice Location: 20 13th St W, Havre, MT 59501 Phone: 406-262-2020 | |
Havre Optometric Clinic, Pllp Optometrist Medicare: Medicare Enrolled Practice Location: 416 3rd Ave, Havre, MT 59501 Phone: 406-265-1231 Fax: 406-265-1603 |